Marco Y. W. Zaki

Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease.

cRel expression regulates distinct transcriptional and functional profiles driving fibroblast matrix production in systemic sclerosis.

TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms.

c-Rel orchestrates energy-dependent epithelial and macrophage reprogramming in fibrosis.

Author Correction: c-Rel orchestrates energy-dependent epithelial and macrophage reprogramming in fibrosis.

Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?

A Role in the Genetic Predisposition to NAFLD-HCC?

Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease.